New understanding of mechanisms of painful diabetic neuropathy: A path to prevention and better treatment?

Scandinavian Journal of Pain

Volumn 4, Issue 3, 2013, Pages 127-128

  Jensen, Troels Staehelin ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS AFFECTING PROTEIN METABOLISM; CCHEMBRIDGE 5861528; INSULIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; UNCLASSIFIED DRUG;

DIABETIC NEUROPATHY; DRUG MECHANISM; DYSLIPIDEMIA; HUMAN; METABOLIC SYNDROME X; NEUROPATHIC PAIN; NONHUMAN; NOTE; PAINFUL DIABETIC NEUROPATHY; PRIORITY JOURNAL; SENSORY DYSFUNCTION; DIABETIC PATIENT; HYPERSENSITIVITY; INSULIN SIGNALING;

EID: 84880039272     PISSN: 18778860     EISSN: 18778879     Source Type: Journal    
DOI: 10.1016/j.sjpain.2013.04.004     Document Type: Note

References (14)

1. Koivisto A., Pertovaara A. Transient receptor potential ankyrin 1 (TRPA1) ion channel in the pathophysiology of peripheral diabetic neuropathy. Scand J Pain 2013, 4:129-136.
2. Abbott C.A., Malik R.A., van Ross E.R., Kulkarni J., Boulton A.J. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care 2011, 34:2220-2224.
3. Callaghan B.C., Cheng H.T., Stables C.L., Smith A.L., Feldman E.L. Diabetic neuropathy: clinical manifestations and current treatment. Lancet Neurol 2012, 11:521-534.
4. Basbaum A.I., Bautista D.M., Scherrer G., Julius D. Cellular and molecular mechanisms of pain. Cell 2009, 139:267-284.
5. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997, 389:816-824.
6. Story G.M., Peier A.M., Reeve A.J., Eid S.R., Mosbacher J., Hricik T.R., Earley T.J., Hergarden A.C., Andersson D.A., Hwang S.W., McIntyre P., Jegla T., Bevan S., Patapoutian A. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 2003, 112:819-829.
7. von Hehn C.A., Baron R., Woolf C.J. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 2012, 73:638-652.
8. Jensen T.S. Neuropathic pain in metabolic and inflammatory diseases. Pain comorbidities - understanding and treating the complex patient 2012, 261-278. IASP Press, Seattle. M.A. Giamberardino, T.S. Jensen (Eds.).
9. Haanpää M., Attal N., Backonja M., Baron R., Bennett M., Bouhassira D., Cruccu G., Hansson P., Haythornthwaite J.A., Iannetti G.D., Jensen T.S., Kauppila T., Nurmikko T.J., Rice A.S., Rowbotham M., Serra J., Sommer C., Smith B.H., Treede R.D. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011, 152:14-27.
10. Jensen T.S., Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain: topical review. Pain 2002, 102:1-8.
11. Koivisto A., Hukkanen M., Saarnilehto M., Chapman H., Kuokkanen K., Wei H., Viisanen H., Akerman K.E., Lindstedt K., Pertovaara A. Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy. Pharmacol Res 2012, 65:149-158.
12. Vincent A.M., Callaghan B.C., Smith A.L., Feldman E.L. Diabetic neuropathy: cellular mechnisms as therapeutic targets. Nat Rev Neurol 2011, 7:573-583.
13. Devigili G., Tugnoli V., Penza P., Camozzi F., Lombardi R., Melli G., Broglio L., Granieri E., Lauria G. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 2008, 131:1912-1925.
14. Finnerup N.B., Sindrup S.H., Jensen T.S. The evidence for pharmacological treatment of neuropathic pain. Pain 2010, 150:573-581.